Cited by 55Migraine and Headache StudiesTraumatic Brain Injury ResearchTemporomandibular Joint Disorders

Medication-overuse headache

Katsarava, Zaza, Obermann, Mark·2013·Current Opinion in Neurology

Abstract

Purpose of review Medication-overuse headache (MOH) is a well described clinical entity. There is a growing body of knowledge on the epidemiology of MOH, risk factors, and treatment strategies. Recent findings The International Headache Society updated the classification criteria for MOH. Population-based studies provided an insight into the prevalence and peculiarities of MOH patients in eastern Europe and Asia. Large-scaled population-based longitudinal studies made it possible to analyze risk factors leading to the development of MOH. Imaging studies helped to better understand the pathophysiology of headache chronicity. New treatment strategies have been suggested. Summary MOH is a common headache disorder and a serious public health problem all over the world. Although the treatment regimen for MOH patients is straightforward and the outcomes are favorable, it is time now to move forward and establish a predictive model for early recognition of patients at high risk, to intervene early and avoid development of chronic headache.

Integrity signals

Registry

Crossref · 10.1097/wco.0b013e328360d596

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Katsarava, Z., & Obermann, M.
Affiliations
University of Duisburg-Essen (DE)
Corresponding author
Katsarava, Zaza
Venue
Current Opinion in Neurology
Published
2013-06
Volume
26
Issue
3
Pages
276-281
ISSN
1350-7540 (ISSN-L)
OpenAlex
W2410760670
Cited by
55
References
70
Citations by year
2024: 1 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 6 · 2017: 2 · 2016: 9 · 2015: 10 · 2014: 10 · 2013: 4 · 2012: 1
FWCI
1.50
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Migraine and Headache Studies
  • Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
  • Health Sciences › Health Professions › Complementary and Manual Therapy › Temporomandibular Joint Disorders
Keywords
medication overuse headache, chronic headache, prevalence, risk factors, headache pathophysiology, headache treatment, prediction model, early recognition, Eastern Europe, Asia
MeSH terms
Acute Disease, Analgesics, Chronic Disease, Ergotamine, Female, Headache, Humans, Male, Migraine Disorders, Prognosis, Recurrence, Time Factors, Vasoconstrictor Agents, Serotonin Receptor Agonists, Sumatriptan, Analgesics, Non-Narcotic, Tension-Type Headache, Headache Disorders, Secondary

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review